In others, waiting until weight stabilizes leads to better, longer-lasting results
Tirzepatide is a novel dual agonist that targets both the GLP-1 receptor and the glucose-dependent insulinotropic polypeptide (GIP) receptor ( 2 Literature search strategy This narrative review aimed to synthesize current mechanistic and clinical evidence regarding tirzepatide in obesity-related OSAS
Myosteatosis alters muscle fiber composition and organization, with a decrease in oxidative, insulin-sensitive fibers and a concomitant increase in relatively fast-fatiguing glycolytic fibers, paralleling the effects observed in obesity and aging
Prompt recognition and medical intervention are essential to prevent further complications, including disabling and potentially life-threatening complications that could result in the wrongful death of a user
Serious side effects like pancreatitis occur in fewer than 1% of users
This can make it very hard for someone to burn body fat even when they severely restrict their calories